1-15 of 15
Dan T. Vogl, MD, MSCE
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Hydroxychloroquine with Infusional Cyclophosphamide, Pulse Dexamethasone and Rapamycin in Patients with Relapsed or Refractory Multiple Myeloma

Emma C. Scott, MD, Dan T. Vogl, MD MSCE, Shara Reasor-Heard, Kevin Floyd, Eva Medvedova, MD, Stephen E. Spurgeon, MD, Miranda Gordon, RN, Anne Kratz, RN, Matthew B. Siegel, MD, Marc Loriaux, MD PhD, Phoebe Trubowitz, MD, Stephen D Smith, MD, Selina Qiuying Liu, Ranjana Arora, MD, Edward A. Stadtmauer, Ravi K. Amaravadi, MD, Richard T. Maziarz, MD
Journal: Blood
Blood (2014) 124 (21): 3449.
https://doi.org/10.1182/blood.V124.21.3449.3449
Published: 2014
Journal Articles

Stem Cell Mobilization With Plerixafor + G-CSF In Comparison To Cyclophosphamide + G-CSF and Time-To-Progression After Autologous Stem Cell Transplantation For Multiple Myeloma

Alfred L. Garfall, MD, Andrew Dougherty, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, Adam D Cohen, MD, David L. Porter, MD, Una O'Doherty, MD, PhD, Patricia Mangan, CRNP, Kathleen Cunningham, RN, Don L. Siegel, M.D., Ph.D.,, Edward A. Stadtmauer, MD
Journal: Blood
Blood (2013) 122 (21): 3354.
https://doi.org/10.1182/blood.V122.21.3354.3354
Published: 2013
Journal Articles

ACY-1215, a Selective Histone Deacetylase (HDAC) 6 Inhibitor: Interim Results Of Combination Therapy With Bortezomib In Patients With Multiple Myeloma (MM)

Noopur Raje, MD, Dan T. Vogl, MD, MSCE, Parameswaran N. Hari, MD, MRCP, MS, Sundar Jagannath, MD, Simon S Jones, PhD, Jeffrey G Supko, PhD, Gina Leone, RN, Catherine Wheeler, MD, Robert Z. Orlowski, M.D., Ph.D., Paul G. Richardson, MD, Sagar Lonial, M.D.
Journal: Blood
Blood (2013) 122 (21): 759.
https://doi.org/10.1182/blood.V122.21.759.759
Published: 2013
Journal Articles

Engineered T-Cells Expressing An HLA-Restricted Affinity-Enhanced TCR In Advanced Multiple Myeloma Patients Post Auto-SCT Engraft and Are Associated With Encouraging Post Auto-SCT Responses

Aaron P. Rapoport, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, Gwendolyn K. Binder-Scholl, PhD, Dominic P. Smethurst, MD, Jeffrey Finklestein, Irina Kulikovskaya, Minnal Gupta, Joanna E. Brewer, PhD, Alan D. Bennett, PhD, Andrew B. Gerry, PhD, Nicholas J. Pumphrey, PhD, Helen K. Tayton-Martin, PhD, Lilliam C. Ribeiro, MBe, Ashraf Badros, MD, Saul Yanovich, MD, Gorgun Akpek, MD, MS, Naseem Kerr, MPH, Sunita Philip, Sandra Westphal, Bruce L. Levine, PhD, Bent K. Jakobsen, PhD, Michael Kalos, PhD, Carl H. June, MD
Journal: Blood
Blood (2013) 122 (21): 766.
https://doi.org/10.1182/blood.V122.21.766.766
Published: 2013
Journal Articles

Phase I/II Dose Expansion Of a Multi-Center Trial Of Carfilzomib and Pomalidomide With Dexamethasone (Car-Pom-d) In Patients With Relapsed/Refractory Multiple Myeloma

Jatin J. Shah, M.D., Edward A. Stadtmauer, MD, Rafat Abonour, MD, Adam D. Cohen, MD, William Bensinger, MD, Cristina Gasparetto, MD, Jonathan L. Kaufman, MD, Suzanne Lentzsch, MD, PhD, Dan T. Vogl, MD, MSCE, Robert Z. Orlowski, M.D., Ph.D., Erica L. Kim, MPH, Natalia Bialas, David D. Smith, PhD, Brian GM Durie, MD
Journal: Blood
Blood (2013) 122 (21): 690.
https://doi.org/10.1182/blood.V122.21.690.690
Published: 2013
Journal Articles

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Aaron P. Rapoport, MD, Nicole A. Aqui, MD, Edward A. Stadtmauer, MD, Ashraf Z. Badros, MD, Dan T. Vogl, MD, MSCE, YinYan Xu, Brendan M Weiss, MD, Ling Cai, PhD, Hong-Bin Fang, PhD, Elizabeth Veloso, RN, JD, Zhaohui Zheng, MA, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Sunita Philip, Kathleen Ruehle, RN, Kelly-Marie Betts, MS, Anne Chew, PhD, Holly McConville, RN, BSN, Sandra Westphal, Scott Strome, Andres Salazar, MD, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 352.
https://doi.org/10.1182/blood.V120.21.352.352
Published: 2012
Journal Articles

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Aaron P. Rapoport, MD, Edward A. Stadtmauer, MD, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, Gwendolyn K. Binder-Scholl, PhD, Joanna E. Brewer, PhD, Alan D. Bennett, PhD, Andrew B. Gerry, PhD, Nick J. Pumphrey, PhD, Dominic P. Smethurst, MD, Helen K. Tayton-Martin, PhD, Ribeiro C. Lilliam, MBe, Elizabeth Veloso, JD, BSN, Zhaohui Zheng, MA, Ashraf Z. Badros, MD, Saul Yanovich, MD, Gorgun Akpek, MD, MHS, Holly McConville, RN, BSN, Naseem Kerr, MPH, Sunita Philip, MPH, Kelly-Marie Betts, MS, Sandra Westphal, Michael Kalos, PhD, Bruce L. Levine, PhD, Bent K. Jakobsen, PhD, Carl H. June, MD
Journal: Blood
Blood (2012) 120 (21): 472.
https://doi.org/10.1182/blood.V120.21.472.472
Published: 2012
Journal Articles

A Single-Center Retrospective Comparison of Post-Transplant Outcomes in Patients Receiving VRD Vs. VD Vs. RD As Initial Therapy Prior to ASCT for Newly Diagnosed Multiple Myeloma (MM)

Nathan C Nussbaum, MD, Andrew Dougherty, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, David L Porter, MD, E Paul Wileyto, Kathleen Cunningham, Patricia A. Mangan, Brenda K. Shelly, Heather DiFilippo, Edward A. Stadtmauer, MD
Journal: Blood
Blood (2012) 120 (21): 2042.
https://doi.org/10.1182/blood.V120.21.2042.2042
Published: 2012
Journal Articles

A Multi-Center Phase I/II Trial of Carfilzomib and Pomalidomide with Dexamethasone (Car-Pom-d) in Patients with Relapsed/Refractory Multiple Myeloma

Jatin J. Shah, M.D., Edward A. Stadtmauer, MD, Rafat Abonour, MD, Adam D Cohen, MD, William I. Bensinger, MD, Cristina Gasparetto, MD, Jonathan L. Kaufman, MD, Suzanne Lentzsch, MD, PhD, Dan T. Vogl, MD, MSCE, Robert Z. Orlowski, M.D., Ph.D., Erica L. Kim, MPH, Marti B. McKinley, BSN, MBA, Brian G M Durie, MD
Journal: Blood
Blood (2012) 120 (21): 74.
https://doi.org/10.1182/blood.V120.21.74.74
Published: 2012
Journal Articles

Rocilinostat (ACY-1215), a Selective HDAC6 Inhibitor, Alone and in Combination with Bortezomib in Multiple Myeloma: Preliminary Results From the First-in-Humans Phase I/II Study

Noopur Raje, MD, Parameswaran N Hari, MD, MRCP, MS, Dan T. Vogl, MD, MSCE, Sundar Jagannath, MD, Robert Z. Orlowski, M.D., Ph.D., Jeffrey G Supko, PhD, Patricia Stephenson, ScD, Simon S Jones, Catherine Wheeler, MD, Sagar Lonial, MD
Journal: Blood
Blood (2012) 120 (21): 4061.
https://doi.org/10.1182/blood.V120.21.4061.4061
Published: 2012
Journal Articles

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Dan T. Vogl, MD, MSCE, Edward A. Stadtmauer, MD, James Bradner, MD, Lisa Davis, PharmD, Thomas M. Paul, Emma C. Scott, MD, Charles W. Nichols, MD, David L. Porter, MD, Martin Carroll, MD, Janeen Kaplan, Gayle Mallon, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Ravi K. Amaravadi, MD
Journal: Blood
Blood (2011) 118 (21): 1869.
https://doi.org/10.1182/blood.V118.21.1869.1869
Published: 2011
Journal Articles

Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edward A. Stadtmauer, MD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Raymond L. Comenzo, MD, Stacey Goodman, MD, Parameswaran Hari, MD, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, Sergio Giralt, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 41.
https://doi.org/10.1182/blood.V116.21.41.41
Published: 2010
Journal Articles

Tandem Autologous Stem Cell Transplants (auto-auto) with or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 Trial

Edward A Stadtmauer, MD, Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Hugo Castro-Malaspina, MD, Adetola A. Kassim, MD, MS, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, J. Douglas Rizzo, MD, MS, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, David G. Maloney, Sergio Giralt, MD
Journal: Blood
Blood (2010) 116 (21): 526.
https://doi.org/10.1182/blood.V116.21.526.526
Published: 2010
Journal Articles

Effect of Pharmacokinetic Variability on the Toxicity and Efficacy of High-Dose Melphalan for Multiple Myeloma

Dan T. Vogl, MD, MSCE, Eric Stoopler, DMD, Lisa Davis, PharmD, Thomas M. Paul, German Salazar, DDS, Maria Raguza-Lopez, David L. Porter, MD, Selina M. Luger, MD, Edward A. Stadtmauer, MD
Journal: Blood
Blood (2010) 116 (21): 1349.
https://doi.org/10.1182/blood.V116.21.1349.1349
Published: 2010
Journal Articles

The Optimal Timing for Stem Cell Collection After Induction Therapy for Patients with Multiple Myeloma

Aziz Nazha, Dan T. Vogl, MD, MSCE, Una O'Doherty, MD, PhD, Patricia Mangan, CRNP, Kathleen Cunningham, RN, Selina Luger, MD, David L. Porter, MD, Stephen J. Schuster, Marie Gardler, Mary Sell, Don L. Siegel, MD, PhD, BSc, Edward A Stadtmauer, MD
Journal: Blood
Blood (2010) 116 (21): 2252.
https://doi.org/10.1182/blood.V116.21.2252.2252
Published: 2010